Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Medtech Ventures | Abdominal Aortic Aneurysm Endovascular Technology and Market Forecasts

Abdominal Aortic Aneurysm Endovascular Technology and Market Forecasts

It is estimated that approximately 4.5 million people in the developed word are living with an abdominal aortic aneurysm and each year 600,000 new cases are diagnosed.

Patients typically have no symptoms and, when they are diagnosed, they often undergo complex open surgical repair. Stent-graft therapy provides a minimally-invasive alternative, with reduced recovery times and potentially improved survival rates.

By the end of 2006 the global market for abdominal aortic aneurysm stent-grafts has reached US$610 million and has been growing at double digit rate.

Technical improvements in graft design and advancement in delivery techniques will result in the increased application of Endovascular Aneurysm Repair (EVAR) and the market is expected to reach US$1.3 billion by 2012.

Medtech Ventures' Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast is an exclusive introduction to this rapidly growing market.

The report provides a brief, but through, analysis of this market with profiles of leading participants and forecasts to the year 2012.

With Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast, you'll be able to better:

- Identify emerging technologies and the companies behind them.

- Leverage your own technology and brain storm new business opportunities.

- Assess market size and growth potential.

- Understand current market dynamics, competitors positions and market shares.

- Assess market potential and have access to forecasts till 2012.

- Monitor the competition's marketed and in-development products.

- Investigate mergers, acquisitions and licensing possibilities

Abdominal Aortic Aneurysm - Endovascular Technology & Market Forecast is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this emerging growth area.

Date Published: July 2007

Number of Pages: 22

PDF Format
Table of Contents

Price

PDF Single User $950.00

PDF Site Licence $1900.00

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions